drugset / Trial / NCT04169854

Pre-emptive Topical Lidocaine 5% Plaster for Prevention of Post-craniotomy Pain

NCT04169854 ↗

Phase 3 Unknown 180 enrolled Beijing Tiantan Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Postcraniotomy pain remains a common phenomenon in the neurosurgery field. Managements for postcraniotomy pain are to be standardised and optimized. In the proposed study, the investigators aim to provide a novel regional non-invasive prophylactic strategy for postcraniotomy pain by utilizing Lidocaine 5% plaster.

Timeline

Start
2020-10-15
Primary completion
2023-01
Completion
2023-01

Outcome

Missed primary endpoint

paper There were no statistically significant differences in the VAS scores at 24 h after craniotomy (P = 0.539). PMID 39691748 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 5 % Topical

Indications

No indication recorded.